Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00498706 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression
A Phase 3 study of Depression, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 3
- Development phase
- 325
- Enrollment target
- 1
- Study location
NCT00498706 is a Phase 3 study of Depression that has completed, run by Northwestern University. The registered enrollment target is 325 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00498706, a Phase 3 study of Depression, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 325 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effectiveness of telephone versus face-to-face administration of cognitive behavioral therapy in treating people with depression.
Conditions Studied
Interventions
- BEHAVIORAL Telephone-administered cognitive behavioral therapy (T-CBT)
- BEHAVIORAL Face-to-face administered CBT (FtF-CBT)
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2007-12 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00498706
The ClinicalTrials.gov registry entry for NCT00498706 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (59% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Telephone-administered cognitive behavioral therapy (T-CBT) is the first listed.
NCT00498706 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00498706 about?
NCT00498706 is a clinical study titled "Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression". This study will compare the effectiveness of telephone versus face-to-face administration of cognitive behavioral therapy in treating people with depression.
What is the current status of trial NCT00498706?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 325 participants. The study started on 2007-12. Estimated completion is 2012-05.
What conditions does trial NCT00498706 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00498706?
The interventions under investigation include: Telephone-administered cognitive behavioral therapy (T-CBT) (BEHAVIORAL), Face-to-face administered CBT (FtF-CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00498706?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00498706 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.